Skip to content

XOMA Corporation XOMA Other Income (Expense)

Other Income (Expense) at other companies

Ligand Pharmaceuticals logo
Ligand PharmaceuticalsLGND
-$41.63M-198%
Royalty Pharma logo
Royalty PharmaRPRX
-$94.78M+5.0%
Theravance Biopharma logo
Theravance BiopharmaTBPH
$3.01M+221%
Innoviva, Inc. logo
Innoviva, Inc.INVA
-$366K+63.3%
Zymeworks logo
ZymeworksZYME
$120K+145%
ALN
Alnylam PharmaceuticalsALNY
-$46.98M-130%

Segments

By segment

See full
Single Reportable$4.72M+5,069%

Other financials

Income statement

See full
Revenue$12.3M-22.6%
Operating income-$480.0K-108%
Net income$4.5M+88.6%
EPS (diluted)$0.17+183%

Balance sheet

See full
Cash & equivalents$85.6M-5.2%
Total debt$124.7M+9.0%
Total equity$92.9M+9.7%
Total assets$271.9M+27.8%

Cash flow

See full
Operating cash flow$6.1M+178%
CapEx$3.0K-29.4%
Free cash flow-$2.9M+36.0%

Valuation

See full
Market cap$746.04M+159%
Enterprise value$785.17M+152%
P/E22.1×
P/S15.4×+8.7×

Profitability

See full
Operating margin10.2%+5.5pp
Net margin69.6%+64.0pp
FCF margin-320%-118pp

Returns & leverage

See full
Return on equity38.1%+35.2pp
Debt / equity1.3×0.0×
Current ratio3.6×-2.0×

Where this comes from

Reported directly by XOMA Corporation in its filing.

Tagged under the XBRL concept us-gaap:OtherNonoperatingIncomeExpense.

The official record: XOMA Corporation’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about XOMA Corporation's other income (expense).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is XOMA Corporation's other income (expense)?
XOMA Corporation (XOMA) reported other income (expense) of $4.76M in Q1 2026.
How has XOMA Corporation's other income (expense) changed year-over-year?
XOMA Corporation's other income (expense) increased by 5110.5% year-over-year, from -$95K to $4.76M.
What is the long-term trend for XOMA Corporation's other income (expense)?
Over 4 years (2021 to 2025), XOMA Corporation's other income (expense) has grown at a 93.2% compound annual growth rate (CAGR), from -$879K to $12.24M.
What does other income (expense) mean?
Net total of all non-operating income and expenses not classified in specific line items — a catch-all for miscellaneous financial items.